Categories: BioTechBusinessDesignHealthTechHumanManufacturingProduct
Shape Biopharmaceuticals focuses on developing a new class of nanoparticle based immunotherapeutics for underserved chronic human diseases.
Investors 2
Funding Rounds 1
Mentions in press and media 5
| Date | Title | Description |
| 15.11.2024 | Shape Biopharmaceuticals: A New Dawn in Immunotherapy | In the world of healthcare, the clock is ticking. The demand for innovative treatments is rising, while resources dwindle. Traditional immunotherapy methods often stumble over high costs and lengthy development timelines. Patients are left ... |
| 15.11.2024 | Shape Biopharmaceuticals wins Venture Kick finale |
The increasing pressure on healthcare systems, driven by rising demand for services and resource constraints, highlights the urgent need for innovative strategies in disease prevention and treatment. Traditional approaches often encounter ... |
| 14.11.2024 | Shape Biopharmaceuticals gets the CHF 150,000 Kick to challenge conventional immunotherapy methods | The increasing pressure on healthcare systems, driven by rising demand for services and resource constraints, highlights the urgent need for innovative strategies in disease prevention and treatment. Traditional approaches often encounter c... |
| 24.04.2024 | CHF 40,000 for video consumption with AI, next-gen immunotherapy, and advanced recycling solutions | Optiverse: Revolutionizing Video Consumption with AI
Optiverse addresses a pressing challenge in today's content-rich environment: the significant time drain experienced by professionals as they engage with lengthy videos. This issue isn't ... |
| 27.03.2024 | Ten startups on a business voyage in Boston |
Selected from over 70 applications by a jury of investors and biotech experts, the ten startups selected for the 18th edition of Venture Leaders Biotech will join the roadshow in Boston, one of the world's most important life science hubs.... |
Reviews 0
